Successful treatment of fluoxetine-induced dystonia with low-dose mianserin

Movement Disorders

Volumn 12, Issue 6, 1997, Pages 1102-1105

  Poyurovsky, M ^a   Schneidman, M ^a   Weizman, A ^a  

^a Technion Medical School   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MIANSERIN;

ADULT; ARTICLE; CASE REPORT; DYSTONIA; EYELID CLOSURE; EYELID REFLEX; HUMAN; MALE; ORBICULARIS OCULI MUSCLE; PRIORITY JOURNAL;

EID: 0030693159     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120650     Document Type: Article

References (22)

1. 1 Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994 ; 165: 728–733.
2. 2 Lipinski JF, Mallya G, Zimmerman P, et al. Fluoxetine‐induced akathisia: clinical and theoretical implications. J Clin Psychiatry 1989: 50: 339–342.
3. 3 Fallen BA, Liebowitz MR. Fluoxetine and extrapyramidal symptoms in CNS lupus. J Clin Psychopharmacol 1991 ; 11: 147–148.
4. 4 Coulter DM, Pillans PI. Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1995 ; 152: 122–125.
5. 5 Casey DE. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non‐human primate models. Br J Psychiatry 1996 ; 168 (suppl 29): 32–39.
6. 6 Meltzer HY, Young GM, Metz J, Fand VS, Schyve PM, Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm 1979 ; 45: 165–175.
7. 7 Reccoppa L, Welch WA, Ware MR. Acute dystonia and fluoxetine [letter]. J Clin Psychiatry 1990 ; 51: 487.
8. 8 Black B, Uhde TW. Acute dystonia and fluoxetine [letter], J Clin Psychiatry 1992 ; 53: 327.
9. 9 Dave M. Fluoxetine‐associated dystonia. Am J Psychiatry 1994 ; 151: 149.
10. 10 Miller CH, Fleishhacker WW, Ehrman H, Kane JM. Treatment of Neuroleptic‐induced akathisia with the 5‐HT antagonist ritanserin. Psychopharmacol Bull 1990 ; 26: 373–376.
11. 11 Weiss D, Aizenberg D, Hermesh D, et al. Cyproheptadine treatment in Neuroleptic‐induced akathisia. Br J Psychiatry 1995 ; 166: 352–357.
12. 12 Maj J, Sowinska H, Baran L, Gancarcyk L, Rawlow A. The central antiserotonergic action of mianserin. Psychopharmacology 1978 ; 59: 79–84.
13. 13 Poyurovsky M, Meerovich I, Weizman A. Beneficial effect of low‐dose mianserin on fluvoxamine‐induced akathisia in an obsessive‐compulsive patient. Int Clin Psychopharmacol 1995 ; 10: 111–115.
14. 14 Poyurovsky M, Kreinin A, Modai I, Weizman A. Lithium‐induced akathisia responds to low‐dose mianserin: case report. Int Clin Psychopharmacol 1995 ; 10: 261–263.
15. 15 Poyurovsky M, Kosov A, Halperin E, Enoch D, Schneidman M, Weizman A. Akathisia‐like behavior following ECT and its successful treatment with low‐dose mianserin. Int Clin Psychopharmacol 1995 ; 10: 257–260.
16. 16 Waldmeier PC, Delini‐Stula AA. Serotonin‐dopamine interactions in the nigrostriatal system. Eur J Pharmacol 1979 ; 55: 363–373.
17. 17 Korsgaard S, Gerlach H, Christensson E. Behavioral aspects of serotonin‐dopamine interactions in monkeys. Abstracts of the 13th C.N.I.P. Congress 1986, Jerusalem, 400.
18. 18 Leo RG. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996 ; 57: 449–454.
19. 19 Zubenko GC, Cohen BM, Lipinski JF Jr. Antidepressant‐related akathisia. J Clin Psychopharmacol 1987 ; 7: 254–257.
20. 20 Poyurovsky M, Fuchs C, Weizman A. Low‐dose mianserin in neuroleptic induced akathisia. Br J Psychiatry (in press; 1997).
21. 21 Povlsen UJ, Noring U, Laurse AML, Korsgaard S, Gerlach J. Effects of serotonergic and anticholinergic drugs in haloperidol‐induced dystonia in Cebus monkeys. Clin Neuropharmacol 1986 ; 9: 84–90.
22. 22 Korsgaard S, Friis T. Effects of mianserin in Neuroleptic‐induced parkinsonism. Psychopharmacology 1978 ; 59: 79–84.